Morgan Stanley
RPID icon

Morgan Stanley’s Rapid Micro Biosystems RPID Stock Holding History

Morgan Stanley’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.7K Sell
27,587
-1,620
-6% -$3.41K ﹤0.01% 6529
2026
Q1 		$66.3K Sell
29,207
-2,182
-7% -$7.99K ﹤0.01% 6306
2025
Q4 		$91K Buy
31,389
+10,839
+53% +$37.6K ﹤0.01% 6242
2025
Q3 		$68.6K Sell
20,550
-15,673
-43% -$49.6K ﹤0.01% 6298
2025
Q2 		$125K Buy
36,223
+16,658
+85% +$48.4K ﹤0.01% 6048
2025
Q1 		$51.7K Buy
19,565
+9,457
+94% +$21.6K ﹤0.01% 6256
2024
Q4 		$9.1K Hold
10,108
– – ﹤0.01% 6836
2024
Q3 		$9K Hold
10,108
– – ﹤0.01% 6747
2024
Q2 		$6.67K Hold
10,108
– – ﹤0.01% 6779
2024
Q1 		$9.8K Sell
10,108
-536
-5% -$521 ﹤0.01% 6715
2023
Q4 		$7.88K Hold
10,644
– – ﹤0.01% 6733
2023
Q3 		$11.5K Buy
10,644
+436
+4% +$433 ﹤0.01% 6683
2023
Q2 		$10.2K Hold
10,208
– – ﹤0.01% 6809
2023
Q1 		$13.4K Sell
10,208
-3,666
-26% -$4.76K ﹤0.01% 6775
2022
Q4 		$15.7K Sell
13,874
-6,919
-33% -$16.7K ﹤0.01% 6777
2022
Q3 		$67K Sell
20,793
-14,034
-40% -$54.5K ﹤0.01% 6270
2022
Q2 		$151K Buy
34,827
+9,895
+40% +$46.1K ﹤0.01% 6031
2022
Q1 		$169K Buy
24,932
+16,596
+199% +$122K ﹤0.01% 6012
2021
Q4 		$89K Buy
8,336
+7,861
+1,655% +$123K ﹤0.01% 6507
2021
Q3 		$9K Buy
+475
New +$9.81K ﹤0.01% 7370

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $8.55M AUM 12.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EFA
Evernest Financial Advisors Carmel, Indiana $478M AUM 24% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley's RPID Position: Q2 2026 in Review

Morgan Stanley reduced its Rapid Micro Biosystems (RPID) stake by 5.5% in Q2 2026, selling an estimated $3.41K and leaving 27,587 shares worth $47.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6529.

Morgan Stanley first reported a position in RPID in Q3 2021 and has held it in 20 quarters since. The position peaked at $169K in Q1 2022. 34 funds tracked by Wall St. Rank hold RPID as of Q2 2026.

  • Morgan Stanley held 27,587 shares of Rapid Micro Biosystems worth $47.7K as of Q2 2026.
  • Morgan Stanley sold 1,620 Rapid Micro Biosystems shares in Q2 2026, an estimated $3.41K.
  • Rapid Micro Biosystems made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6529 holding.
  • Morgan Stanley first reported a position in Rapid Micro Biosystems in Q3 2021 and has held it in 20 quarters since.
  • Morgan Stanley's Rapid Micro Biosystems position peaked at $169K in Q1 2022.
  • 34 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.